Xenon Pharmaceuticals to Present at the Bank of America Securities Biotech SMID Cap Conference 2022

Rhea-AI Summary

Xenon Pharmaceuticals Inc. (Nasdaq:XENE) announced its participation in one-on-one investor meetings and a fireside chat at the Bank of America Securities Biotech SMID Cap Conference 2022. The event will be held virtually on December 7-8, 2022. Ian Mortimer, President and CEO, along with Sherry Aulin, CFO, will present on December 7 at 1:10 pm Eastern Time. A webcast of the presentation will be accessible on the company’s website for later viewing. Xenon Pharmaceuticals focuses on developing innovative therapies for neurological disorders, particularly epilepsy.

BURNABY, British Columbia, Nov. 30, 2022 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a neurology-focused biopharmaceutical company, today announced that management will participate in one-on-one investor meetings and a fireside chat presentation at the Bank of America Securities Biotech SMID Cap Conference 2022 taking place virtually from December 7-8, 2022.

Fireside Chat/Company Presentation Details:

Date:	Wednesday, December 7, 2022
Time:	1:10 pm Eastern Time (10:10 am Pacific Time)
Presenters:	Ian Mortimer, President and CEO
	Sherry Aulin, CFO

A webcast of the fireside chat/company presentation will be available on the “Investors” section of Xenon's website and posted for replay following the event. The above listed dates and times are subject to change.

About Xenon Pharmaceuticals Inc.

Xenon Pharmaceuticals (NASDAQ:XENE) is a clinical stage biopharmaceutical company committed to developing innovative therapeutics to improve the lives of patients with neurological disorders. We are advancing a novel product pipeline of neurology therapies to address areas of high unmet medical need, with a focus on epilepsy. For more information, please visit www.xenon-pharma.com.

“Xenon” and the Xenon logo are registered trademarks or trademarks of Xenon Pharmaceuticals Inc. in various jurisdictions. All other trademarks belong to their respective owner.

Investor/Media Contact:
Jodi Regts
Xenon Pharmaceuticals Inc.
Phone: 604.484.3353
Email: investors@xenon-pharma.com

FAQ

What date is Xenon Pharmaceuticals presenting at the Bank of America Securities Biotech SMID Cap Conference?

Xenon Pharmaceuticals will present on December 7, 2022.

Who will represent Xenon Pharmaceuticals at the conference?

Ian Mortimer, President and CEO, and Sherry Aulin, CFO, will represent the company.

What time is Xenon Pharmaceuticals' presentation during the conference?

The presentation is scheduled for 1:10 pm Eastern Time.

How can I watch the Xenon Pharmaceuticals presentation?

The presentation will be available via a webcast on Xenon's website and can be replayed later.

What is the focus of Xenon Pharmaceuticals?

Xenon Pharmaceuticals focuses on developing therapeutics for neurological disorders, especially epilepsy.